Cargando…

Effect of Intravenous Abciximab on Coronary Flow Improvement After Re-vascularization in Primary Coronary Intervention and Short Term Impact

INTRODUCTION: Of recognized fact the importance of early diagnosis and early management of ST-elevation myocardial infarction, to regain a normal or at least adequate coronary flow in the Primary Percutaneous Intervention. Slow or no-reflow is suboptimal myocardial reperfusion, without angiographic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rgeeb, Ahmed N., Alsalkh, Hussein A., Radhi, Ali Kadhim, Amber, Khalid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Medical Sciences of Bosnia and Herzegovina 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520065/ https://www.ncbi.nlm.nih.gov/pubmed/33041442 http://dx.doi.org/10.5455/medarh.2020.74.265-269

Ejemplares similares

Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention
por: Vergara-Jimenez, Jennifer, et al.
Publicado: (2010)

Intracoronary versus Intravenous Administration of Abciximab in Patients with Acute Coronary Syndrome: A Meta-Analysis
por: Wang, Jie-Ning, et al.
Publicado: (2013)

Abciximab: a reappraisal of its use in coronary care
por: Valgimigli, Marco, et al.
Publicado: (2008)

The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary
por: Iversen, Allan, et al.
Publicado: (2008)

Hemorrhagic pericarditis with cardiac tamponade after percutaneous coronary intervention associated with the use of abciximab
por: Moon, Su-Jin, et al.
Publicado: (2008)

Complications of intracoronary abciximab bolus-only versus standard protocol during percutaneous coronary intervention in acute coronary syndrome
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2014)

Comparison between Intracoronary Abciximab and Intravenous Eptifibatide Administration during Primary Percutaneous Coronary Intervention of Acute ST-Segment Elevation Myocardial Infarction
por: Namazi, Mohammad Hasan, et al.
Publicado: (2013)

Abciximab: Abciximab-induced alveolar haemorrhage: case report
Publicado: (2021)

A case of successful primary coronary intervention for the total occlusion of left main stem with the aid of abciximab.
por: Jeong, M. H., et al.
Publicado: (2001)

Evaluate Short-Term Outcomes of abciximab in ST-Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Clinical Trials
por: Bai, Nan, et al.
Publicado: (2022)

Anti-inflammatory Effect of Abciximab-Coated Stent in a Porcine Coronary Restenosis Model
por: Hong, Young Joon, et al.
Publicado: (2007)

Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration
por: Gu, Youlan L, et al.
Publicado: (2009)

Efficacy and Safety of Abciximab in Diabetic Patients Who Underwent Percutaneous Coronary Intervention with Thienopyridines Loading: A Meta-Analysis
por: Wu, Yihua, et al.
Publicado: (2011)

Effects of abciximab on key pattern of human coronary restenosis in vitro: impact of the SI/MPL-ratio
por: Voisard, Rainer, et al.
Publicado: (2006)

Acute Profound Thrombocytopenia after Using Abciximab for No-Reflow during Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
por: Park, Soonyoung, et al.
Publicado: (2013)

Alveolar Hemorrhage during Abciximab Infusion
por: Koza, Yavuzer, et al.
Publicado: (2021)

Long-Term Clinical Benefits of a Platelet Glycoprotein IIb/IIIa Receptor Blocker, Abciximab (ReoPro(®)), in High-Risk Diabetic Patients undergoing Percutaneous Coronary Intervention
por: Sim, Doo Sun, et al.
Publicado: (2003)

Effect of a Dual Drug-Coated Stent With Abciximab and Alpha-Lipoic Acid in a Porcine Coronary Restenosis Model
por: Lim, Kyung Seob, et al.
Publicado: (2011)

Early administration of abciximab reduces mortality in female patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the EUROTRANSFER Registry)
por: Dziewierz, Artur, et al.
Publicado: (2012)

Spontaneous Bleeding from Internal Pudendal Artery associated with Abciximab after Primary Percutaneous Coronary Intervention: Successful Treatment with Percutaneous Gel-Foam Embolization
por: Lee, Seung-Eun, et al.
Publicado: (2016)

The Long-term Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: ReoPro(®)) Coated Stent in Patients with Coronary Artery Disease
por: Kim, Weon, et al.
Publicado: (2004)

Short- and long-term outcomes following percutaneous coronary intervention in hepatitis C virus seropositive patients
por: Hussein, Ahmed, et al.
Publicado: (2020)

Bilateral subconjunctival hemorrhage secondary to abciximab use: case report
por: Kul, Selim, et al.
Publicado: (2017)

Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris during percutaneous coronary interventions under an adjunctive antithrombotic therapy with abciximab: design and rationale of the High Intensity Transient Signals ReoPro (HITS-RP) study
por: Kretzschmar, Daniel, et al.
Publicado: (2012)

Efficacy of Femoral Vascular Closure Devices in Patients Treated with Anticoagulant, Abciximab or Thrombolytics during Percutaneous Endovascular Procedures
por: Kim, Ha Young, et al.
Publicado: (2006)

Efficacy of Combination Treatment with Intracoronary Abciximab and Aspiration Thrombectomy on Myocardial Perfusion in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Stenting
por: Ahn, Sung Gyun, et al.
Publicado: (2014)

Short-Term Effect of Percutaneous Coronary Intervention on Heart Rate Variability in Patients with Coronary Artery Disease
por: Yan, Chang, et al.
Publicado: (2021)

Improved short and long term survival associated with percutaneous coronary intervention in the elderly patients with acute coronary syndrome
por: Chen, Xiaojing, et al.
Publicado: (2018)

Eptifibatide is associated with significant cost savings and similar clinical outcomes to abciximab when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction: An observational cohort study of 3863 patients
por: Rathod, KS, et al.
Publicado: (2017)

Long-term outcomes after fractional flow reserve-guided percutaneous coronary intervention in patients with severe coronary stenosis
por: Zhang, Ying-Hua, et al.
Publicado: (2019)

Efficacy of intravenous eptifibatide in primary percutaneous coronary intervention patients
por: Jalalian, Rozita, et al.
Publicado: (2021)

Prediction of short-term clinical outcome of percutaneous coronary intervention in patients with acute coronary syndrome through myeloperoxidase levels
por: Pourmoghaddas, Ali, et al.
Publicado: (2014)

Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting
por: Kumar, Ratan, et al.
Publicado: (2020)

Effects of intravenous caffeine on fractional flow reserve measurements in coronary artery disease
por: Mutha, Vivek, et al.
Publicado: (2014)

Effect of intravenous infusion of iodinated contrast media on the coronary blood flow in dogs
por: Abd, Thura T., et al.
Publicado: (2016)

Coronary Flow Reserve in Non-Infarcted Myocardium Predicts Long-Term Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention
por: Cheng, Rongchao, et al.
Publicado: (2018)

Flow Regulation in Coronary Vascular Tree: A Model Study
por: Xie, Xinzhou, et al.
Publicado: (2015)

Multivessel Coronary Artery Disease and Subsequent Thrombolysis in Myocardial Infarction Flow Grade After Primary Percutaneous Coronary Intervention
por: Majeed, Haris, et al.
Publicado: (2020)

Short-term outcome of percutaneous coronary intervention with directional coronary atherectomy followed by drug-coated balloon: a preliminary report
por: Sato, Akihiko, et al.
Publicado: (2018)

Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
por: Chen, Shih-Chin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6i796ba3huvg5becmpt8jcqoca